Formulation of two-layer dissolving polymeric microneedle patches for insulin transdermal delivery in diabetic mice.

Dissolving microneedles (MNs) display high efficiency in delivering poorly permeable drugs and vaccines. Here, two-layer dissolving polymeric MN patches composed of gelatin and sodium carboxymethyl cellulose (CMC) were fabricated with a two-step casting and centrifuging process to localize the insulin in the needle and achieve efficient transdermal delivery of insulin. In vitro skin insertion capability was determined by staining with tissue-marking dye after insertion, and the real-time penetration depth was monitored using optical coherence tomography. Confocal microscopy images revealed that the rhodamine 6G and fluorescein isothiocyanate-labeled insulin (insulin-FITC) can gradually diffuse from the puncture sites to deeper tissue. Ex vivo drug-release profiles showed that 50% of the insulin was released and penetrated across the skin after 1 h, and the cumulative permeation reached 80% after 5 h. In vivo and pharmacodynamic studies were then conducted to estimate the feasibility of the administration of insulin-loaded dissolving MN patches on diabetic mice for glucose regulation. The total area above the glucose level versus time curve as an index of hypoglycemic effect was 128.4 ± 28.3 (% h) at 0.25 IU/kg. The relative pharmacologic availability and relative bioavailability (RBA) of insulin from MN patches were 95.6 and 85.7%, respectively. This study verified that the use of gelatin/CMC MN patches for insulin delivery achieved a satisfactory RBA compared to traditional hypodermic injection and presented a promising device to deliver poorly permeable protein drugs for diabetic therapy. © 2016 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 105A: 84-93, 2017.

[1]  Henry T. Peng,et al.  Hydrogel-elastomer composite biomaterials: 2. Effects of aging methacrylated gelatin solutions on the preparation and physical properties of interpenetrating polymer networks , 2007, Journal of materials science. Materials in medicine.

[2]  Jung-Hwan Park,et al.  Dissolving microneedles for transdermal drug delivery. , 2008, Biomaterials.

[3]  T. Aminabhavi,et al.  Polymeric hydrogels for oral insulin delivery. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[4]  Keizo Fukushima,et al.  Two-layered dissolving microneedles formulated with intermediate-acting insulin. , 2012, International journal of pharmaceutics.

[5]  Keizo Fukushima,et al.  Two-Layered Dissolving Microneedles for Percutaneous Delivery of Peptide/Protein Drugs in Rats , 2010, Pharmaceutical Research.

[6]  Sabu Thomas,et al.  Pectin/carboxymethyl cellulose/microfibrillated cellulose composite scaffolds for tissue engineering. , 2013, Carbohydrate polymers.

[7]  Antonios G Mikos,et al.  Gelatin as a delivery vehicle for the controlled release of bioactive molecules. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[8]  Wijaya Martanto,et al.  Transdermal Delivery of Insulin Using Microneedles in Vivo , 2004, Pharmaceutical Research.

[9]  Kunal Pal,et al.  Calcium alginate-carboxymethyl cellulose beads for colon-targeted drug delivery. , 2015, International journal of biological macromolecules.

[10]  Der-Zen Liu,et al.  Swelling/Floating Capability and Drug Release Characterizations of Gastroretentive Drug Delivery System Based on a Combination of Hydroxyethyl Cellulose and Sodium Carboxymethyl Cellulose , 2015, PloS one.

[11]  Akira Yamamoto,et al.  The development and characteristics of novel microneedle arrays fabricated from hyaluronic acid, and their application in the transdermal delivery of insulin. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[12]  Mark R Prausnitz,et al.  Microneedles for transdermal drug delivery. , 2004, Advanced drug delivery reviews.

[13]  Hsing-Wen Sung,et al.  A review of the prospects for polymeric nanoparticle platforms in oral insulin delivery. , 2011, Biomaterials.

[14]  Akira Yamamoto,et al.  Transdermal delivery of relatively high molecular weight drugs using novel self-dissolving microneedle arrays fabricated from hyaluronic acid and their characteristics and safety after application to the skin. , 2014, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[15]  Göran Stemme,et al.  Novel Microneedle Patches for Active Insulin Delivery are Efficient in Maintaining Glycaemic Control: An Initial Comparison with Subcutaneous Administration , 2007, Pharmaceutical Research.

[16]  H. Szajewska,et al.  Continuous subcutaneous insulin infusion vs. multiple daily injections in children with type 1 diabetes: a systematic review and meta‐analysis of randomized control trials , 2009, Pediatric diabetes.

[17]  Israel Hartman Insulin Analogs: Impact on Treatment Success, Satisfaction, Quality of Life, and Adherence , 2008, Clinical Medicine & Research.

[18]  J. Skogsberg,et al.  Improved treatment satisfaction but no difference in metabolic control when using continuous subcutaneous insulin infusion vs. multiple daily injections in children at onset of type 1 diabetes mellitus , 2008, Pediatric diabetes.

[19]  L. Niskanen,et al.  FlexPen: addressing issues of confidence and convenience in insulin delivery. , 2005, Clinical therapeutics.

[20]  Yukako Ito,et al.  Two-layered dissolving microneedles for percutaneous delivery of sumatriptan in rats , 2011, Drug development and industrial pharmacy.

[21]  P. Raskin,et al.  Review of clinical trials: update on oral insulin spray formulation , 2010 .

[22]  Kanji Takada,et al.  Antigen-loaded dissolving microneedle array as a novel tool for percutaneous vaccination. , 2012, Vaccine.

[23]  Mei-Chin Chen,et al.  Dissolving polymer microneedle patches for rapid and efficient transdermal delivery of insulin to diabetic rats. , 2013, Acta biomaterialia.

[24]  Jung-Hwan Park,et al.  Hydrogel swelling as a trigger to release biodegradable polymer microneedles in skin. , 2012, Biomaterials.

[25]  Yukako Ito,et al.  Transdermal insulin application system with dissolving microneedles. , 2012, Diabetes technology & therapeutics.

[26]  Meng-Tsan Tsai,et al.  Fabrication of a novel partially dissolving polymer microneedle patch for transdermal drug delivery. , 2015, Journal of materials chemistry. B.

[27]  Robert Langer,et al.  Transdermal drug delivery , 2008, Nature Biotechnology.

[28]  Xiu-lan Li,et al.  Characteristics of calcium sulfate/gelatin composite biomaterials for bone repair , 2007, Journal of Biomaterials Science. Polymer Edition.

[29]  L. Heinemann,et al.  Reduction of Postprandial Glycemic Excursions in Patients with Type 1 Diabetes: A Novel Human Insulin Formulation versus a Rapid-Acting Insulin Analog and Regular Human Insulin , 2011, Journal of diabetes science and technology.

[30]  J. Gumprecht,et al.  Insulin therapy - new directions of research. , 2016, Endokrynologia Polska.

[31]  N. Roxhed,et al.  Intradermal Insulin Delivery , 2014, Journal of diabetes science and technology.

[32]  Yukako Ito,et al.  Self-dissolving micropile array tips for percutaneous administration of insulin , 2010, Journal of materials science. Materials in medicine.

[33]  S. Mitragotri,et al.  Current status and future potential of transdermal drug delivery , 2004, Nature Reviews Drug Discovery.

[34]  Thomas R Kreil,et al.  Emerging trends in plasma‐free manufacturing of recombinant protein therapeutics expressed in mammalian cells , 2009, Biotechnology journal.

[35]  Mark R Prausnitz,et al.  Faster pharmacokinetics and increased patient acceptance of intradermal insulin delivery using a single hollow microneedle in children and adolescents with type 1 diabetes , 2013, Pediatric diabetes.

[36]  J. King,et al.  Mathematical modelling of the release of drug from porous, nonswelling transdermal drug-delivery devices. , 1998, IMA journal of mathematics applied in medicine and biology.

[37]  S. Genuth,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[38]  R. Barbucci,et al.  Carboxymethyl cellulose-hydroxyapatite hybrid hydrogel as a composite material for bone tissue engineering applications. , 2014, Journal of biomedical materials research. Part A.

[39]  A. Lendlein,et al.  Biocompatibility and inflammatory response in vitro and in vivo to gelatin-based biomaterials with tailorable elastic properties. , 2014, Biomaterials.

[40]  Henry T. Peng,et al.  Hydrogel-elastomer composite biomaterials: 3. Effects of gelatin molecular weight and type on the preparation and physical properties of interpenetrating polymer networks , 2008, Journal of materials science. Materials in medicine.

[41]  G. Chiou,et al.  Alternative delivery of insulin via eye drops. , 2005, Diabetes technology & therapeutics.

[42]  B. Zinman,et al.  Alternative routes of insulin delivery , 2003, Diabetic medicine : a journal of the British Diabetic Association.